NCT02880540View on ClinicalTrials.gov

Dexmedetomidine to Treat Bariatric Surgery-associated Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Obesity
Interventions
DRUG

Fentanyl

DRUG

Morphine

DRUG

Dexmedetomidine

Trial Locations (1)

20010

Childrens National Medical Center, Washington D.C.

All Listed Sponsors
lead

Janelle Vaughns

OTHER

NCT02880540 - Dexmedetomidine to Treat Bariatric Surgery-associated Pain | Biotech Hunter | Biotech Hunter